Literature DB >> 434951

Circulating immune complexes and monocyte Fc function in autoimmune diseases.

M Kávai, K Lukács, I Sonkoly, K Páloczi, G Szegedi.   

Abstract

The phagocytosis of separated and adherent monocytes of patients with systemic lupus erythematosus is subnormal as compared to controls on the basis of latex and yeast uptake. The monocytes from the same patients react with antibody-coated sheep red blood cells in a significantly higher degree than normal monocytes. There is a correlation between the percentage of reactive monocytes and the serum immune complex content. After brief treatment of patients with levamisole the phagocytic function of monocytes is restored and at the same time the circulating immune complex content is decreased.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434951      PMCID: PMC1000325          DOI: 10.1136/ard.38.1.79

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Effects of levamisole on human monocyte function and immunoprotein receptors.

Authors:  M E Schmidt; S D Douglas
Journal:  Clin Immunol Immunopathol       Date:  1976-11

2.  Lack of correlation of activated monocytes with lymphocyte function in patients with lymphoma.

Authors:  A L Sagone; S Kamps; R Campbell; G W King
Journal:  J Reticuloendothel Soc       Date:  1977-06

3.  Radioassay of soluble immune complexes using their uptake by macrophage Fc receptors.

Authors:  M Kávai; K Dankó; E Kalmár; I Francia; G Szegedi
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

4.  Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells.

Authors:  I I Onyewotu; E J Holborow; G D Johnson
Journal:  Nature       Date:  1974-03-08       Impact factor: 49.962

5.  Receptor sites of human monocytes for IgG.

Authors:  H Huber; H H Fudenberg
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

6.  Differences in the immune and non-immune interaction of peritoneal macrophages from the Biozzi high and low responder lines of mice with sheep red blood cells.

Authors:  E Wiener; A Bandieri
Journal:  J Reticuloendothel Soc       Date:  1977-05

7.  The phagocytic capacity of macrophages in the S phase of the cell cycle.

Authors:  A Reikvam
Journal:  Cell Immunol       Date:  1977-06-15       Impact factor: 4.868

8.  Immunoreactivity to nuclear antigens in systemic lupus erythematosus with or without nephritis, and in other connective tissue diseases, with particular reference to the RNA-protein antigen.

Authors:  J C Mulli; A Cruchaud
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

9.  Phagocyte function and cell-mediated immunity in systemic lupus erythematosus.

Authors:  M Landry
Journal:  Arch Dermatol       Date:  1977-02

10.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Authors:  J B Winfield; I Faiferman; D Koffler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

View more
  8 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  Cellular phagocytic studies in rheumatoid arthritis patients treated with levamisole.

Authors:  K M Wynne; P A Dieppe; J Scott; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

3.  Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids.

Authors:  N P Hurst; B Bessac; G Nuki
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

4.  Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).

Authors:  N P Hurst; G Nuki; T Wallington
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

5.  Activity of circulating monocytes in patients with chronic glomerulonephritis.

Authors:  Z Hruby; W Kopeć; Z Szewczyk
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

6.  Human peripheral blood monocytes display surface antigens recognized by monoclonal antinuclear antibodies.

Authors:  V M Holers; B L Kotzin
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

7.  Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; A Laffon; D Alarcón-Segovia
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

8.  Mononuclear phagocytes in rheumatoid arthritis: Fc-receptor expression by peripheral blood monocytes.

Authors:  S D Carter; J T Bourne; C J Elson; C W Hutton; R Czudek; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.